Since the passage of the Dietary Supplement Health and Education Act (DSHEA) 30 years ago, the U.S. dietary supplement market has grown into a vast industry that has little in common with its DSHEA-era predecessor. Over the years, the retroactive structure of DSHEA has encouraged the influx of bad actors who have identified the dietary supplement sector as a venue for the introduction of unapproved drugs into the U.S. market.
Fill out the form to read the full article.
Required *